Fill out the form below to download the app note.

As more cell therapies progress through the clinical pipeline to commercial manufacturing, transitioning your process to a closed, modular workflow reduces the number of manual steps and open processes and helps standardize the production of T cell therapeutics by improving their quality and safety while reducing costs.

As part of our initiative to provide workflows that support closed cell therapy manufacturing, we are highlighting the incorporation of magnetic bead separation technology into a cell processing platform designed specifically for cell therapy applications. This app note provides you with a step-by-step guide on the procedure for T cell isolation and activation with Gibco CTS Dynabeads using the Gibco CTS Rotea counterflow centrifugation system and the Gibco CTS DynaMag Magnet.

In this app note, you’ll learn about:

(*Indicates a mandatory field)